What You Should Know:
- Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers.
- The study will encompass both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition,
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare
Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications.
How Can Pharmacogenomics Improve Outcomes?
By considering a person’s DNA in treatment options, providers can determine how an
Read More
Sharecare Launches SaaS for Independent Decentralized Clinical Research
What You Should Know:
- Today, Sharecare announced the launch of Smart Omix, Sharecare's new scalable SaaS-based solution to empower independent researchers, clinicians, and academic institutions to conduct digitally enabled clinical research studies
- Smart Omix is made for researchers by researchers and purpose-built to address technological, economic, and talent barriers to remote observational studies more commonly encountered by
Read More
Power Launches with $7M to Diversify Clinical Trials
What You Should Know:
- Power, a patient-friendly platform designed to improve access to clinical trial studies emerges from stealth with $7M in seed funding.
- The round was led by Footwork and CRV, with additional investments from ARTIS Ventures, South Park Commons, and AirAngels to help Power bring the process of discovering and accessing clinical trials into the future.
Modernising and Simplifying Accessibility to Clinical Trials
Eighty-six percent
Read More
AI More Accurate for Cardiac Diagnosis than Echocardiogram Assessments
What You Should Know:
- In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
- The results, announced during a late-breaking presentation at the European Society of Cardiology Congress 2022, have immediate
Read More
Realizing the Dream of AI in Clinical Trials—How to Address Key Challenges
The clinical development process is incredibly time consuming and only yields a success rate of about 10%. One way to reduce the time, cost and success of the clinical development process is to introduce artificial intelligence (AI) into clinical trials and implement AI-driven process automation.
The dream of AI in clinical trial execution is for trial functions to run autonomously, like a self-driving car. A self-driving car knows how fast it is going, where it needs to go,
Read More
Biotia Raises $8M to Fight Infectious Diseases Powered by AI & Genomics
What You Should Know:
- Biotia, a company fighting infectious diseases powered by genomics and artificial intelligence (AI), has raised an oversubscribed $8 million Series A round led by OCA Ventures.
- OCA, a veteran early-stage venture firm operating from Chicago and Palo Alto was joined by other key investors including Continuum Health Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Digital-Dx Ventures, and others. Prior Seed round investors include Falcon II
Read More
Using AI to Match Patients with Clinical Trials for Proactive Treatment
We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. One of the more significant solutions that support the faster and more efficient development of new pharmaceutical products – such as the COVID-19 vaccine, which was developed faster than any other vaccine in history – is artificial intelligence (AI)-driven data analysis. Thanks to modern life science technology
Read More
Avenda Health Receives FDA Exemption for AI-Enabled Prostate Cancer Therapy
What You Should Know:
- Avenda Health, an AI healthcare company creating the future of prostate cancer care, has received FDA Investigational Device Exemption (IDE) for its FocalPoint ablation system. The IDE will allow the technology, powered by iQuest, to be used in a randomized control trial to show superiority over the standard of care for the treatment of prostate cancer.
- FocalPoint is Avenda Health’s focal laser ablation system designed to treat localized prostate cancer
Read More
H1 Launches AI-Powered and Evidence-Based Interactions
What You Should Know:
- H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.
- New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.
Establishing AI-Driven Efficient Workflows
H1 is
Read More
